- 2025 revenue €5.673bn (‑10.9%); EBITDA pre-exceptionals €510m (‑16.9%); net financial liabilities €2.023bn (‑15%); Urethane Systems sold on 1 Apr 2025.
- Additional permanent cost reductions ~€100m targeted by end‑2028 including 550 job cuts (≈two‑thirds in Germany), plus ~€50m production‑network savings for total structural ~€150m by end‑2028; FORWARD! has delivered ~€150m pa since end‑2025.
- 2026 outlook: EBITDA pre‑exceptionals guided at €450–550m with recovery expected no earlier than H2 2026.
Fiscal 2025 results
Revenue fell 10.9% to €5.673bn; EBITDA pre-exceptionals declined 16.9% to €510m, with a pre-ex margin of 9.0% (9.6% prior). Weak demand, lower volumes, reduced raw-material costs, Asian price pressure, absence of Urethane Systems earnings after its sale on 1 April 2025 and adverse currency effects drove the decline.
Cost measures
LANXESS initiated additional permanent savings of ~€100m by end-2028, including 550 planned job cuts (≈two‑thirds in Germany) focused on administrative functions, plus earlier production-network optimizations (announced Aug 2025) expected to save ~€50m, totaling ~€150m structural savings by end-2028; the FORWARD! plan has delivered ~€150m annual savings since end-2025. Short-term measures include a 35‑hour workweek for collective-bargaining employees through year-end and no base-salary increases for non-covered staff.
Balance sheet
Net financial liabilities decreased to €2.023bn at end-2025 (‑15% vs end-2024), mainly due to proceeds from the Urethane Systems sale.
Segments
Consumer Protection: sales €1.889bn (‑9.2%); EBITDA pre-ex €290m (+1.4%); margin 15.4%. Specialty Additives: sales €2.056bn (‑6.9%); EBITDA pre-ex €201m (‑11.5%); margin 9.8%. Advanced Intermediates: sales €1.653bn (‑8.4%); EBITDA pre-ex €128m (‑39%); margin 7.7%.
Outlook
2026 EBITDA pre-exceptionals guided at €450–550m; positive momentum is expected no earlier than H2 2026.
